Oliver Bandmann

13PUBLICATIONS
38CO-AUTHORS
Pacific Peoples medicine and treatmentsToxicology (incl. clinical toxicology)PharmacogenomicsEpigenetics (incl. genome methylation and epigenomics)Medical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 22, 2026
Ursodeoxycholic Acid and Parkinson's Disease Risk: An Emulated Target Trial in UK Electronic Health Records.

|Jul 18, 2025
Neuroprotection in Parkinson Disease.

Cristina Gonzalez-Robles, Oliver Bandmann, Anthony H V Schapira

|Apr 18, 2025
Treatment Selection and Prioritization for the EJS ACT-PD MAMS Trial Platform.

Cristina Gonzalez-Robles, Dilan Athauda, Thomas R Barber

|May 20, 2024
Polygenic Risk Scores Validated in Patient-Derived Cells Stratify for Mitochondrial Subtypes of Parkinson's Disease.

Giuseppe Arena, Zied Landoulsi, Dajana Grossmann

|Dec 07, 2023
Multimodal assessment of mitochondrial function in Parkinson's disease.

Thomas Payne, Toby Burgess, Stephen Bradley

|Sep 07, 2023
The master energy homeostasis regulator PGC-1α exhibits an mRNA nuclear export function.

Simeon R Mihaylov, Lydia M Castelli, Ya-Hui Lin

Pageof 3

Frequent Collaborators

3 joint publications

Thomas Foltynie

2 joint publications

Thomas Payne

2 joint publications

Sonja W Scholz

2 joint publications

Cristina Gonzalez-Robles